查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
行动医疗市场：按类型、用途、相关人员分类：2023-2032 年全球机会分析与产业预测
市场调查报告书
商品编码
1365571

行动医疗市场：按类型、用途、相关人员分类：2023-2032 年全球机会分析与产业预测

mHealth Market By Type, By Application, By Stakeholders : Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 350 Pages | 商品交期: 2-3个工作天内

价格

根据Allied Market Research发布的新报告《 mHealth Market 》，2022年mHealth市场价值将达到707亿美元，2023年至2032年年复合成长率为18%，到2032年预计将达到707亿美元。

行动医疗（mHealth）被定义为在医疗保健中使用智慧型手机和平板电脑等行动装置来支援医疗和公共卫生实践。行动医疗主要涉及使用无线技术来监测和治疗多种急性和慢性疾病，例如糖尿病、高血压和心臟病。

行动医疗市场-IMG1

推动全球行动医疗市场成长的主要要素包括医疗设备技术的快速进步、慢性心臟疾病患者数量的增加，这将进一步增加对监控心臟病患者的行动医疗设备的需求。糖尿病患病不断上升。例如，根据美国疾病管制与预防中心 (CDC) 2022 年的数据，2020 年美国约有 697,000 人死于心臟病。此外，根据 2022 年国家卫生统计中心的数据，每 20比例就有一名美国人心臟病发作。因此，每年有超过100万美国人心臟病发作。

然而，对确保法规合规性的担忧预计将限制行动医疗市场的成长。相反，新兴国家医疗保健支出的快速增长以及对更好治疗方案的医疗保健需求未得到满足，预计将为未来全球市场扩张创造利润丰厚的机会。

目录

第1章简介

第2章执行摘要

第3章市场概况

  • 市场定义和范围
  • 主要发现
    • 影响要素
    • 主要投资机会
  • 波特五力分析
  • 市场动态
    • 促进因素
      • 心臟疾病患病
      • 糖尿病罹患率增加
      • 对行动健康和穿戴式装置的需求增加
    • 抑制因素
      • 对确保法规合规性的担忧
    • 机会
      • 新兴国家的高成长潜力
      • 老年人口增加
  • COVID-19 市场影响分析

第4章行动医疗市场：按类型

  • 概述
  • 行动健康设备
    • 按设备类型分類的行动医疗设备市场
  • 米健康服务
    • 按服务类型分類的行动医疗服务行动医疗市场

第5章行动医疗市场：依用途

  • 概述
  • 心血管
  • 糖尿病
  • 呼吸系统
  • 神经
  • 其他的

第6章行动医疗市场：相关人员

  • 业务概要
  • 行动电信商
  • 终端厂商
  • 医疗提供者
  • 应用程式/内容提供者

第7章行动医疗市场：按地区

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 澳洲
    • 印度
    • 韩国
    • 其他的
  • 拉丁美洲/中东/非洲
    • 巴西
    • 沙乌地阿拉伯
    • 南非
    • 其他的

第8章竞争形势

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争仪表板
  • 竞争热图
  • 2022年主要企业定位

第9章公司简介

  • Boston Scientific Corporation
  • DexCom, Inc.
  • Fitbit
  • Koninklijke Philips NV
  • Medtronic plc
  • Omada Health
  • Omron Corporation.
  • 南美SUNG ELECTRONICS CO., LTD.
  • Welldoc, Inc
  • Teladoc Health, Inc.
Product Code: A00015

According to a new report published by Allied Market Research, titled, "mHealth Market," The mhealth market was valued at $70.7 billion in 2022, and is estimated to reach $370.7 billion by 2032, growing at a CAGR of 18% from 2023 to 2032. Mobile health (mHealth) is defined as the use of mobile devices, such as smartphones and tablets, in healthcare to support medical and public health practice. mHealth majorly involves the use of wireless technologies, which are deployed in monitoring and treatment of several acute and chronic disorders such as diabetes, hypertension, heart diseases, and others.

mHealth Market - IMG1

Major factors that drive the growth of the global mHealth market include rapid technological advancements in medical devices, increase in the number of patients suffering from chronic heart diseases, which further increase the demand for mHealth devices for monitoring heart disease patients, and rise in prevalence of diabetes. For instance, according to the Centers for Disease Control and Prevention (CDC) 2022, about 697,000 people in the U.S died from heart disease in 2020. In addition, according to a National Center for Health Statistics 2022, in every 20 seconds one American suffers a heart attack. Thus, more than 1 million Americans have a heart attack each year.

However, concerns related to ensuring regulatory compliance are expected to restrict the growth of the mHealth market. On the contrary, surge in healthcare expenditure and unmet medical demands to get better treatment options in developing countries are expected to create lucrative opportunities for the expansion of the global market in the future.

The mHealth market is segmented on the basis of type, application, stakeholder, and region. On the basis of type, the market is classified into mHealth devices and mHealth services. The mHealth devices segment is further categorized into blood glucose meter, blood pressure monitors, pulse oximetry, neurological monitors, cardiac monitors, apnea & sleep monitors, wearable fitness sensor device & heart rate meters, and others. The mHealth service segment is further categorized into prevention services, diagnostic services, monitoring services, treatment services, and wellness & healthcare system strengthening solutions. By application, the mHealth market classified into cardiovascular, diabetes, respiratory, neurology, and others. By stakeholder, the mHealth market is divided into mobile operators, device vendors, healthcare providers, and application & content players. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

The major players profiled in the report are Boston Scientific Corporation, DexCom, Inc., FITBIT, INC. (Google), Koninklijke Philips N.V., Medtronic plc, Omada Health, Omron Corporation, SAMSUNG ELECTRONICS CO., LTD., Teladoc Health, Inc., and Welldoc, Inc. These major players have adopted product approval, agreement, acquisition, collaboration, merger, and product launch as key developmental strategies to improve the product portfolio of the mHealth market.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the mhealth market analysis from 2022 to 2032 to identify the prevailing mhealth market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the mhealth market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global mhealth market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 20% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline talk to the sales executive to know more)

  • Market share analysis of players by products/segments
  • New Product Development/ Product Matrix of Key Players
  • Average Selling Price Analysis / Price Point Analysis
  • Criss-cross segment analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)
  • SWOT Analysis

Key Market Segments

By Type

  • mHealth Devices
    • Device Type
    • Blood Glucose Monitors
    • Blood Pressure Monitors
    • Pulse Oximetry
    • Neurological Monitors
    • Cardiac Monitors
    • Apnea and Sleep Monitors
    • Wearable Fitness Sensor Devices and Heart Rate Meters
    • Others
  • mHealth Services
    • Service Type
    • Prevention Services
    • Diagnostic Services
    • Monitoring Services
    • Treatment Services
    • Wellness and Healthcare System Strengthening Solutions

By Application

  • Cardiovascular
  • Diabetes
  • Respiratory
  • Neurology
  • Others

By Stakeholders

  • Mobile operator
  • Device Vendors
  • Healthcare Providers
  • Application and Content Players

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Boston Scientific Corporation
    • DexCom, Inc.
    • Fitbit
    • Koninklijke Philips N.V.
    • Medtronic plc
    • Omada Health
    • Omron Corporation.
    • SAMSUNG ELECTRONICS CO., LTD.
    • Teladoc Health, Inc.
    • Welldoc, Inc

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Low bargaining power of suppliers
    • 3.3.2. Low threat of new entrants
    • 3.3.3. Low threat of substitutes
    • 3.3.4. Low intensity of rivalry
    • 3.3.5. Low bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Rise in prevalence of cardiac diseases
      • 3.4.1.2. Increase in the incidence rate of diabetes
      • 3.4.1.3. Increase in demand for mHealth and wearable devices
    • 3.4.2. Restraints
      • 3.4.2.1. Concerns related to ensuring regulatory compliance
    • 3.4.3. Opportunities
      • 3.4.3.1. High growth potential in developing countries
      • 3.4.3.2. Rise in geriatric population
  • 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: MHEALTH MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. mHealth Devices
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
    • 4.2.4. mHealth Devices mHealth Market by Device Type
  • 4.3. mHealth Services
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
    • 4.3.4. mHealth Services mHealth Market by Service Type

CHAPTER 5: MHEALTH MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Cardiovascular
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Diabetes
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Respiratory
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Neurology
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country
  • 5.6. Others
    • 5.6.1. Key market trends, growth factors and opportunities
    • 5.6.2. Market size and forecast, by region
    • 5.6.3. Market share analysis by country

CHAPTER 6: MHEALTH MARKET, BY STAKEHOLDERS

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Mobile operator
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Device Vendors
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Healthcare Providers
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country
  • 6.5. Application and Content Players
    • 6.5.1. Key market trends, growth factors and opportunities
    • 6.5.2. Market size and forecast, by region
    • 6.5.3. Market share analysis by country

CHAPTER 7: MHEALTH MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key trends and opportunities
    • 7.2.2. Market size and forecast, by Type
    • 7.2.3. Market size and forecast, by Application
    • 7.2.4. Market size and forecast, by Stakeholders
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Key market trends, growth factors and opportunities
      • 7.2.5.1.2. Market size and forecast, by Type
      • 7.2.5.1.3. Market size and forecast, by Application
      • 7.2.5.1.4. Market size and forecast, by Stakeholders
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Key market trends, growth factors and opportunities
      • 7.2.5.2.2. Market size and forecast, by Type
      • 7.2.5.2.3. Market size and forecast, by Application
      • 7.2.5.2.4. Market size and forecast, by Stakeholders
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Key market trends, growth factors and opportunities
      • 7.2.5.3.2. Market size and forecast, by Type
      • 7.2.5.3.3. Market size and forecast, by Application
      • 7.2.5.3.4. Market size and forecast, by Stakeholders
  • 7.3. Europe
    • 7.3.1. Key trends and opportunities
    • 7.3.2. Market size and forecast, by Type
    • 7.3.3. Market size and forecast, by Application
    • 7.3.4. Market size and forecast, by Stakeholders
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Key market trends, growth factors and opportunities
      • 7.3.5.1.2. Market size and forecast, by Type
      • 7.3.5.1.3. Market size and forecast, by Application
      • 7.3.5.1.4. Market size and forecast, by Stakeholders
      • 7.3.5.2. France
      • 7.3.5.2.1. Key market trends, growth factors and opportunities
      • 7.3.5.2.2. Market size and forecast, by Type
      • 7.3.5.2.3. Market size and forecast, by Application
      • 7.3.5.2.4. Market size and forecast, by Stakeholders
      • 7.3.5.3. UK
      • 7.3.5.3.1. Key market trends, growth factors and opportunities
      • 7.3.5.3.2. Market size and forecast, by Type
      • 7.3.5.3.3. Market size and forecast, by Application
      • 7.3.5.3.4. Market size and forecast, by Stakeholders
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Key market trends, growth factors and opportunities
      • 7.3.5.4.2. Market size and forecast, by Type
      • 7.3.5.4.3. Market size and forecast, by Application
      • 7.3.5.4.4. Market size and forecast, by Stakeholders
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Key market trends, growth factors and opportunities
      • 7.3.5.5.2. Market size and forecast, by Type
      • 7.3.5.5.3. Market size and forecast, by Application
      • 7.3.5.5.4. Market size and forecast, by Stakeholders
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Key market trends, growth factors and opportunities
      • 7.3.5.6.2. Market size and forecast, by Type
      • 7.3.5.6.3. Market size and forecast, by Application
      • 7.3.5.6.4. Market size and forecast, by Stakeholders
  • 7.4. Asia-Pacific
    • 7.4.1. Key trends and opportunities
    • 7.4.2. Market size and forecast, by Type
    • 7.4.3. Market size and forecast, by Application
    • 7.4.4. Market size and forecast, by Stakeholders
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Key market trends, growth factors and opportunities
      • 7.4.5.1.2. Market size and forecast, by Type
      • 7.4.5.1.3. Market size and forecast, by Application
      • 7.4.5.1.4. Market size and forecast, by Stakeholders
      • 7.4.5.2. China
      • 7.4.5.2.1. Key market trends, growth factors and opportunities
      • 7.4.5.2.2. Market size and forecast, by Type
      • 7.4.5.2.3. Market size and forecast, by Application
      • 7.4.5.2.4. Market size and forecast, by Stakeholders
      • 7.4.5.3. Australia
      • 7.4.5.3.1. Key market trends, growth factors and opportunities
      • 7.4.5.3.2. Market size and forecast, by Type
      • 7.4.5.3.3. Market size and forecast, by Application
      • 7.4.5.3.4. Market size and forecast, by Stakeholders
      • 7.4.5.4. India
      • 7.4.5.4.1. Key market trends, growth factors and opportunities
      • 7.4.5.4.2. Market size and forecast, by Type
      • 7.4.5.4.3. Market size and forecast, by Application
      • 7.4.5.4.4. Market size and forecast, by Stakeholders
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Key market trends, growth factors and opportunities
      • 7.4.5.5.2. Market size and forecast, by Type
      • 7.4.5.5.3. Market size and forecast, by Application
      • 7.4.5.5.4. Market size and forecast, by Stakeholders
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Key market trends, growth factors and opportunities
      • 7.4.5.6.2. Market size and forecast, by Type
      • 7.4.5.6.3. Market size and forecast, by Application
      • 7.4.5.6.4. Market size and forecast, by Stakeholders
  • 7.5. LAMEA
    • 7.5.1. Key trends and opportunities
    • 7.5.2. Market size and forecast, by Type
    • 7.5.3. Market size and forecast, by Application
    • 7.5.4. Market size and forecast, by Stakeholders
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Key market trends, growth factors and opportunities
      • 7.5.5.1.2. Market size and forecast, by Type
      • 7.5.5.1.3. Market size and forecast, by Application
      • 7.5.5.1.4. Market size and forecast, by Stakeholders
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Key market trends, growth factors and opportunities
      • 7.5.5.2.2. Market size and forecast, by Type
      • 7.5.5.2.3. Market size and forecast, by Application
      • 7.5.5.2.4. Market size and forecast, by Stakeholders
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Key market trends, growth factors and opportunities
      • 7.5.5.3.2. Market size and forecast, by Type
      • 7.5.5.3.3. Market size and forecast, by Application
      • 7.5.5.3.4. Market size and forecast, by Stakeholders
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Key market trends, growth factors and opportunities
      • 7.5.5.4.2. Market size and forecast, by Type
      • 7.5.5.4.3. Market size and forecast, by Application
      • 7.5.5.4.4. Market size and forecast, by Stakeholders

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

  • 9.1. Boston Scientific Corporation
    • 9.1.1. Company overview
    • 9.1.2. Key Executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
    • 9.1.7. Key strategic moves and developments
  • 9.2. DexCom, Inc.
    • 9.2.1. Company overview
    • 9.2.2. Key Executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
    • 9.2.7. Key strategic moves and developments
  • 9.3. Fitbit
    • 9.3.1. Company overview
    • 9.3.2. Key Executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
  • 9.4. Koninklijke Philips N.V.
    • 9.4.1. Company overview
    • 9.4.2. Key Executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Business performance
    • 9.4.7. Key strategic moves and developments
  • 9.5. Medtronic plc
    • 9.5.1. Company overview
    • 9.5.2. Key Executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
    • 9.5.6. Business performance
    • 9.5.7. Key strategic moves and developments
  • 9.6. Omada Health
    • 9.6.1. Company overview
    • 9.6.2. Key Executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
    • 9.6.6. Key strategic moves and developments
  • 9.7. Omron Corporation.
    • 9.7.1. Company overview
    • 9.7.2. Key Executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
    • 9.7.6. Business performance
    • 9.7.7. Key strategic moves and developments
  • 9.8. SAMSUNG ELECTRONICS CO., LTD.
    • 9.8.1. Company overview
    • 9.8.2. Key Executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
    • 9.8.6. Business performance
  • 9.9. Welldoc, Inc
    • 9.9.1. Company overview
    • 9.9.2. Key Executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
    • 9.9.6. Key strategic moves and developments
  • 9.10. Teladoc Health, Inc.
    • 9.10.1. Company overview
    • 9.10.2. Key Executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio
    • 9.10.6. Business performance
    • 9.10.7. Key strategic moves and developments

LIST OF TABLES

  • TABLE 01. GLOBAL MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 02. MHEALTH MARKET FOR MHEALTH DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. GLOBAL MHEALTH DEVICES MHEALTH MARKET, BY DEVICE TYPE, 2022-2032 ($MILLION)
  • TABLE 04. MHEALTH MARKET FOR MHEALTH SERVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 05. GLOBAL MHEALTH SERVICES MHEALTH MARKET, BY SERVICE TYPE, 2022-2032 ($MILLION)
  • TABLE 06. GLOBAL MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 07. MHEALTH MARKET FOR CARDIOVASCULAR, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. MHEALTH MARKET FOR DIABETES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 09. MHEALTH MARKET FOR RESPIRATORY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. MHEALTH MARKET FOR NEUROLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. MHEALTH MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 13. MHEALTH MARKET FOR MOBILE OPERATOR, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. MHEALTH MARKET FOR DEVICE VENDORS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. MHEALTH MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. MHEALTH MARKET FOR APPLICATION AND CONTENT PLAYERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. MHEALTH MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. NORTH AMERICA MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 19. NORTH AMERICA MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 20. NORTH AMERICA MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 21. NORTH AMERICA MHEALTH MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 22. U.S. MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 23. U.S. MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 24. U.S. MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 25. CANADA MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 26. CANADA MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 27. CANADA MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 28. MEXICO MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 29. MEXICO MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 30. MEXICO MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 31. EUROPE MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 32. EUROPE MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 33. EUROPE MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 34. EUROPE MHEALTH MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 35. GERMANY MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 36. GERMANY MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 37. GERMANY MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 38. FRANCE MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 39. FRANCE MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 40. FRANCE MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 41. UK MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 42. UK MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 43. UK MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 44. ITALY MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 45. ITALY MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 46. ITALY MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 47. SPAIN MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 48. SPAIN MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 49. SPAIN MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 50. REST OF EUROPE MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 51. REST OF EUROPE MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 52. REST OF EUROPE MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 53. ASIA-PACIFIC MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 54. ASIA-PACIFIC MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 55. ASIA-PACIFIC MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 56. ASIA-PACIFIC MHEALTH MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 57. JAPAN MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 58. JAPAN MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 59. JAPAN MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 60. CHINA MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 61. CHINA MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 62. CHINA MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 63. AUSTRALIA MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 64. AUSTRALIA MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 65. AUSTRALIA MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 66. INDIA MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 67. INDIA MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 68. INDIA MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 69. SOUTH KOREA MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 70. SOUTH KOREA MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 71. SOUTH KOREA MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 72. REST OF ASIA-PACIFIC MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 73. REST OF ASIA-PACIFIC MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 74. REST OF ASIA-PACIFIC MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 75. LAMEA MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 76. LAMEA MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 77. LAMEA MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 78. LAMEA MHEALTH MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 79. BRAZIL MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 80. BRAZIL MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 81. BRAZIL MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 82. SAUDI ARABIA MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 83. SAUDI ARABIA MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 84. SAUDI ARABIA MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 85. SOUTH AFRICA MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 86. SOUTH AFRICA MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 87. SOUTH AFRICA MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 88. REST OF LAMEA MHEALTH MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 89. REST OF LAMEA MHEALTH MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 90. REST OF LAMEA MHEALTH MARKET, BY STAKEHOLDERS, 2022-2032 ($MILLION)
  • TABLE 91. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
  • TABLE 92. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 93. BOSTON SCIENTIFIC CORPORATION: PRODUCT SEGMENTS
  • TABLE 94. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 95. BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
  • TABLE 96. DEXCOM, INC.: KEY EXECUTIVES
  • TABLE 97. DEXCOM, INC.: COMPANY SNAPSHOT
  • TABLE 98. DEXCOM, INC.: PRODUCT SEGMENTS
  • TABLE 99. DEXCOM, INC.: PRODUCT PORTFOLIO
  • TABLE 100. DEXCOM, INC.: KEY STRATERGIES
  • TABLE 101. FITBIT: KEY EXECUTIVES
  • TABLE 102. FITBIT: COMPANY SNAPSHOT
  • TABLE 103. FITBIT: PRODUCT SEGMENTS
  • TABLE 104. FITBIT: PRODUCT PORTFOLIO
  • TABLE 105. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
  • TABLE 106. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
  • TABLE 107. KONINKLIJKE PHILIPS N.V.: PRODUCT SEGMENTS
  • TABLE 108. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
  • TABLE 109. KONINKLIJKE PHILIPS N.V.: KEY STRATERGIES
  • TABLE 110. MEDTRONIC PLC: KEY EXECUTIVES
  • TABLE 111. MEDTRONIC PLC: COMPANY SNAPSHOT
  • TABLE 112. MEDTRONIC PLC: PRODUCT SEGMENTS
  • TABLE 113. MEDTRONIC PLC: PRODUCT PORTFOLIO
  • TABLE 114. MEDTRONIC PLC: KEY STRATERGIES
  • TABLE 115. OMADA HEALTH: KEY EXECUTIVES
  • TABLE 116. OMADA HEALTH: COMPANY SNAPSHOT
  • TABLE 117. OMADA HEALTH: PRODUCT SEGMENTS
  • TABLE 118. OMADA HEALTH: PRODUCT PORTFOLIO
  • TABLE 119. OMADA HEALTH: KEY STRATERGIES
  • TABLE 120. OMRON CORPORATION.: KEY EXECUTIVES
  • TABLE 121. OMRON CORPORATION.: COMPANY SNAPSHOT
  • TABLE 122. OMRON CORPORATION.: SERVICE SEGMENTS
  • TABLE 123. OMRON CORPORATION.: PRODUCT PORTFOLIO
  • TABLE 124. OMRON CORPORATION.: KEY STRATERGIES
  • TABLE 125. SAMSUNG ELECTRONICS CO., LTD.: KEY EXECUTIVES
  • TABLE 126. SAMSUNG ELECTRONICS CO., LTD.: COMPANY SNAPSHOT
  • TABLE 127. SAMSUNG ELECTRONICS CO., LTD.: PRODUCT SEGMENTS
  • TABLE 128. SAMSUNG ELECTRONICS CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 129. WELLDOC, INC: KEY EXECUTIVES
  • TABLE 130. WELLDOC, INC: COMPANY SNAPSHOT
  • TABLE 131. WELLDOC, INC: PRODUCT SEGMENTS
  • TABLE 132. WELLDOC, INC: PRODUCT PORTFOLIO
  • TABLE 133. WELLDOC, INC: KEY STRATERGIES
  • TABLE 134. TELADOC HEALTH, INC.: KEY EXECUTIVES
  • TABLE 135. TELADOC HEALTH, INC.: COMPANY SNAPSHOT
  • TABLE 136. TELADOC HEALTH, INC.: PRODUCT SEGMENTS
  • TABLE 137. TELADOC HEALTH, INC.: PRODUCT PORTFOLIO
  • TABLE 138. TELADOC HEALTH, INC.: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 01. MHEALTH MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF MHEALTH MARKET, 2022-2032
  • FIGURE 03. MHEALTH MARKET,2022-2032
  • FIGURE 04. TOP INVESTMENT POCKETS IN MHEALTH MARKET (2023-2032)
  • FIGURE 05. LOW BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. LOW THREAT OF NEW ENTRANTS
  • FIGURE 07. LOW THREAT OF SUBSTITUTES
  • FIGURE 08. LOW INTENSITY OF RIVALRY
  • FIGURE 09. LOW BARGAINING POWER OF BUYERS
  • FIGURE 10. GLOBAL MHEALTH MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. MHEALTH MARKET, BY TYPE, 2022(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF MHEALTH MARKET FOR MHEALTH DEVICES, BY COUNTRY 2022-2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF MHEALTH MARKET FOR MHEALTH SERVICES, BY COUNTRY 2022-2032(%)
  • FIGURE 14. MHEALTH MARKET, BY APPLICATION, 2022(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF MHEALTH MARKET FOR CARDIOVASCULAR, BY COUNTRY 2022-2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF MHEALTH MARKET FOR DIABETES, BY COUNTRY 2022-2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF MHEALTH MARKET FOR RESPIRATORY, BY COUNTRY 2022-2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF MHEALTH MARKET FOR NEUROLOGY, BY COUNTRY 2022-2032(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF MHEALTH MARKET FOR OTHERS, BY COUNTRY 2022-2032(%)
  • FIGURE 20. MHEALTH MARKET, BY STAKEHOLDERS, 2022(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF MHEALTH MARKET FOR MOBILE OPERATOR, BY COUNTRY 2022-2032(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF MHEALTH MARKET FOR DEVICE VENDORS, BY COUNTRY 2022-2032(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF MHEALTH MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY 2022-2032(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF MHEALTH MARKET FOR APPLICATION AND CONTENT PLAYERS, BY COUNTRY 2022-2032(%)
  • FIGURE 25. MHEALTH MARKET BY REGION, 2022
  • FIGURE 26. U.S. MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 27. CANADA MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. MEXICO MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. GERMANY MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. FRANCE MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. UK MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. ITALY MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. SPAIN MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. REST OF EUROPE MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. JAPAN MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. CHINA MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. AUSTRALIA MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. INDIA MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. SOUTH KOREA MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. REST OF ASIA-PACIFIC MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. BRAZIL MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. SAUDI ARABIA MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. SOUTH AFRICA MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 44. REST OF LAMEA MHEALTH MARKET, 2022-2032 ($MILLION)
  • FIGURE 45. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 48. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 49. COMPETITIVE DASHBOARD
  • FIGURE 50. COMPETITIVE HEATMAP: MHEALTH MARKET
  • FIGURE 51. TOP PLAYER POSITIONING, 2022
  • FIGURE 52. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 53. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 54. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 55. DEXCOM, INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 56. DEXCOM, INC.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 57. KONINKLIJKE PHILIPS N.V.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 58. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 59. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 60. MEDTRONIC PLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 61. MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 62. MEDTRONIC PLC: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 63. OMRON CORPORATION.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 64. OMRON CORPORATION.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 65. OMRON CORPORATION.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 66. SAMSUNG ELECTRONICS CO. LTD.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 67. SAMSUNG ELECTRONICS CO. LTD.: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 68. SAMSUNG ELECTRONICS CO. LTD.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 69. TELADOC HEALTH, INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 70. TELADOC HEALTH, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 71. TELADOC HEALTH, INC.: REVENUE SHARE BY REGION, 2022 (%)